Quarterly report · Q2
9273.TEDINET S100Q755
Period2022-07-01 → 2022-12-31
Filed2023-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.2bn | 2022-07-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥20.4bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥10.4bn | 2021-07-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥2.2bn | 2022-07-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥2.2bn | 2021-07-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.2bn | 2022-07-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥3.8bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.1bn | 2021-07-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.2bn | 2022-07-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.1bn | 2021-07-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2022-07-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.4bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.4bn | 2021-07-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.4bn | 2022-07-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥1.4bn | 2021-07-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥27.6bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥26.2bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥25.7bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥8.1bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥7.6bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥19.6bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥18.7bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥17.7bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥8.9bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.1bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.2bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.4bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.2bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.6bn | at 2021-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥518m | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥440m | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥120m | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥477m | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥264m | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥600m | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥805m | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥576m | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥35.19 | 2022-07-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.9 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥59.55 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥35.28 | 2021-07-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥19.98 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 70.8% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.1% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.9% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-12-31 | −¥925m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-12-31 | −¥925m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-12-31 | ¥22m |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥8.1bn |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥7.2bn |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥925m |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥1.4bn |
| jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥4.0bn |
| jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥761m |
| —segment total | revenue | 2022-07-01 → 2022-12-31 | ¥12.1bn |
| —segment total | revenue external | 2022-07-01 → 2022-12-31 | ¥11.2bn |
| —segment total | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥925m |
| —segment total | segment profit | 2022-07-01 → 2022-12-31 | ¥2.1bn |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2021-12-31 | −¥964m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2021-12-31 | −¥964m |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-12-31 | ¥19m |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥7.4bn |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥6.5bn |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | revenue intersegment | 2021-07-01 → 2021-12-31 | ¥964m |
| jpcrp040300-q2r_E34071-000Drug Substance Sales Businessreportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥1.3bn |
| jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥3.9bn |
| jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥3.9bn |
| jpcrp040300-q2r_E34071-000Pharmaceutical Marketing Businessreportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥862m |
| —segment total | revenue | 2021-07-01 → 2021-12-31 | ¥11.3bn |
| —segment total | revenue external | 2021-07-01 → 2021-12-31 | ¥10.4bn |
| —segment total | revenue intersegment | 2021-07-01 → 2021-12-31 | ¥964m |
| —segment total | segment profit | 2021-07-01 → 2021-12-31 | ¥2.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 499
| Item | Context | Value | Unit |
|---|---|---|---|
| Raw materials and supplies | Prior1YearInstant | 384702000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 434854000 | JPY |
| Other ca | Prior1YearInstant | 160572000 | JPY |
| Other ca | CurrentQuarterInstant | 144318000 | JPY |
| Current assets | Prior1YearInstant | 19405821000 | JPY |
| Current assets | CurrentQuarterInstant | 21007297000 | JPY |
| Buildings and structures | Prior1YearInstant | 4853376000 | JPY |
| Buildings and structures | CurrentQuarterInstant | 4880362000 | JPY |
| Accumulated depreciation buildings and structures | Prior1YearInstant | -2144793000 | JPY |
| Accumulated depreciation buildings and structures | CurrentQuarterInstant | -2242470000 | JPY |
| Buildings and structures net | Prior1YearInstant | 2708583000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 2637892000 | JPY |
| Machinery equipment and vehicles | Prior1YearInstant | 3714364000 | JPY |
| Machinery equipment and vehicles | CurrentQuarterInstant | 3724542000 | JPY |
| Accumulated depreciation machinery equipment and vehicles | Prior1YearInstant | -1910485000 | JPY |
| Accumulated depreciation machinery equipment and vehicles | CurrentQuarterInstant | -2101046000 | JPY |
| Machinery equipment and vehicles net | Prior1YearInstant | 1803878000 | JPY |
| Machinery equipment and vehicles net | CurrentQuarterInstant | 1623495000 | JPY |
| Tools furniture and fixtures | Prior1YearInstant | 1252664000 | JPY |
| Tools furniture and fixtures | CurrentQuarterInstant | 1277676000 | JPY |
| Accumulated depreciation tools furniture and fixtures | Prior1YearInstant | -1032481000 | JPY |
| Accumulated depreciation tools furniture and fixtures | CurrentQuarterInstant | -1060231000 | JPY |
| Tools furniture and fixtures net | Prior1YearInstant | 220182000 | JPY |
| Tools furniture and fixtures net | CurrentQuarterInstant | 217444000 | JPY |
| Land | Prior1YearInstant | 1761774000 | JPY |
| Land | CurrentQuarterInstant | 1761774000 | JPY |
| Construction in progress | Prior1YearInstant | 48723000 | JPY |
| Construction in progress | CurrentQuarterInstant | 63635000 | JPY |
| Property plant and equipment | Prior1YearInstant | 6543142000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 6304242000 | JPY |
| Other ia | Prior1YearInstant | 52740000 | JPY |
| Other ia | CurrentQuarterInstant | 42848000 | JPY |
| Intangible assets | Prior1YearInstant | 52740000 | JPY |
| Intangible assets | CurrentQuarterInstant | 42848000 | JPY |
| Investment securities | Prior1YearInstant | 63731000 | JPY |
| Investment securities | CurrentQuarterInstant | 63544000 | JPY |
| Deferred tax assets | Prior1YearInstant | 138633000 | JPY |
| Deferred tax assets | CurrentQuarterInstant | 164600000 | JPY |
| Net defined benefit asset | Prior1YearInstant | 34262000 | JPY |
| Net defined benefit asset | CurrentQuarterInstant | 27034000 | JPY |
| Other ioa | Prior1YearInstant | 11602000 | JPY |
| Other ioa | CurrentQuarterInstant | 16582000 | JPY |
| Investments and other assets | Prior1YearInstant | 248229000 | JPY |
| Investments and other assets | CurrentQuarterInstant | 271762000 | JPY |
| Noncurrent assets | Prior1YearInstant | 6844113000 | JPY |
| Noncurrent assets | CurrentQuarterInstant | 6618853000 | JPY |
| Assets | Prior1YearInstant | 26249934000 | JPY |
| Assets | CurrentQuarterInstant | 27626150000 | JPY |
| Notes and accounts payable trade | Prior1YearInstant | 1464164000 | JPY |
| Notes and accounts payable trade | CurrentQuarterInstant | 2020697000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |